Lista de obras - Hye Won Lee - Dominio Público Uruguay

A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient

artículo científico publicado en 2014

A multi-center study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy

scientific article published on 27 August 2020

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study.

artículo científico publicado en 2018

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

scientific article published in 2022

Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis.

artículo científico publicado en 2017

An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.

artículo científico publicado en 2015

An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate

artículo científico publicado en 2020

An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia

scientific article published on 02 April 2020

Combination therapy with anti-TIM3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma

artículo científico publicado en 2020

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals

artículo científico publicado en 2019

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy.

artículo científico publicado en 2017

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

artículo científico publicado en 2013

Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?

scientific article published on 17 February 2020

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety

artículo científico publicado en 2018

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis

artículo científico publicado en 2017

Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus

scientific article published on 28 April 2020

Entecavirandtenofoviron renal function in patients with hepatitis B virus related hepatocellular carcinoma

artículo científico publicado en 2020

Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures

artículo científico publicado en 2018

External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy

scientific article published on 06 June 2019

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B

artículo científico publicado en 2020

Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.

artículo científico publicado en 2017

Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers

artículo científico publicado en 2018

Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature

artículo científico publicado en 2014

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy

scientific article published on 20 February 2020

Hepatitis B Virus Cure: Targets and Future Therapies

artículo científico publicado en 2020

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

artículo científico publicado en 2020

Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank

artículo científico publicado en 2020

Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

artículo científico publicado en 2017

Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2018

Metabolic activity assessment by 18F-FDG PET in patients with hepatocellular carcinoma undergoing Yttrium-90 TARE

artículo científico publicado en 2020

Postoperative Effects of Thiopurines in Patients with Intestinal Behçet's Disease.

artículo científico publicado en 2015

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response

artículo científico publicado en 2015

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients

artículo científico publicado en 2016

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.

artículo científico publicado en 2014

Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis

artículo científico publicado en 2019

Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.

artículo científico publicado en 2017

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation

artículo científico publicado en 2020

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals

artículo científico publicado en 2019

Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection

scientific article published on 11 January 2019

Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease

artículo científico publicado en 2017

Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.

artículo científico publicado en 2015

Roadmap to Resuming Care for Liver Diseases after COVID-19

scientific article published on 13 July 2020

Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus

artículo científico publicado en 2020

Serotonin signals through a gut-liver axis to regulate hepatic steatosis

artículo científico publicado en 2018

Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.

artículo científico publicado en 2017

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis

artículo científico publicado en 2022

Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

artículo científico publicado en 2017

The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease

artículo científico publicado en 2016

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter

artículo científico publicado en 2017

The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B

scientific article published on 30 December 2019

The severity of liver fibrosis predicts poor cardiovascular outcomes in patients with type 2 diabetes

artículo científico publicado en 2020

Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B

artículo científico publicado en 2020

Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

artículo científico publicado en 2017

Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease

artículo científico publicado en 2020

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease

artículo científico publicado en 2016

Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir

artículo científico publicado en 2020

Lista de obras de Hye Won Lee

A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient

A multi-center study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study.

Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis.

An evaluation of entecavir for the treatment of chronic hepatitis B infection in adults.

An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate

An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia

Combination therapy with anti-TIM3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy.

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?

Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety

Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis

Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus

Entecavirandtenofoviron renal function in patients with hepatitis B virus related hepatocellular carcinoma

Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures

External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy

Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B

Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.

Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers

Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy

Hepatitis B Virus Cure: Targets and Future Therapies

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals

Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank

Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.

Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease

Metabolic activity assessment by 18F-FDG PET in patients with hepatocellular carcinoma undergoing Yttrium-90 TARE

Postoperative Effects of Thiopurines in Patients with Intestinal Behçet's Disease.

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients

Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy.

Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis

Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.

Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals

Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection

Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease

Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.

Roadmap to Resuming Care for Liver Diseases after COVID-19

Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus

Serotonin signals through a gut-liver axis to regulate hepatic steatosis

Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.

Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis

Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter

The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B

The severity of liver fibrosis predicts poor cardiovascular outcomes in patients with type 2 diabetes

Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B

Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease

Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir